Viewing Study NCT00134667


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2025-12-25 @ 10:37 PM
Study NCT ID: NCT00134667
Status: TERMINATED
Last Update Posted: 2007-01-15
First Post: 2005-08-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
Sponsor: Eyetech Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module